New Cambridge spin-out raises $11 million in funding to develop revolutionary new drug for thrombosis, which causes heart attacks and strokes.
A new collaboration based at the University of Cambridge will aim to discover and develop new medicines to treat liver disease.
Cambridge scientists are employing fragment-based drug discovery approaches - a technique that involves "growing" potent drugs from tiny chemical...
Can better decisions be made about which anticancer drugs to progress to clinical trials?
Fundamental research is pioneering innovative approaches to cancer diagnosis and treatment at the Hutchison/MRC Research Centre.
GlaxoSmithKline (GSK) has signed its first agreement with the University to optimise the early clinical development of new GSK medicines for obesity...
A new Cambridge programme aims to meet the challenges of drug discovery by harnessing a spectrum of academic expertise.
